Wu, D. et al. The SARS-CoV-2 outbreak: What we know. Int. J. Infect. Dis. 9444–48 (2020).
Guo, YR et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak—An update on the status. One thousand. Med.Res. 7(1), 1–10 (2020).
Sarcar, C. et al. Potential therapeutic options for COVID-19, current status, challenges, and future perspectives. Front. Pharmacol. eleven1428 (2020).
Funk, CD, Laferrière, C. & Ardakani, A. Target product profile analysis of COVID-19 vaccines in phase III clinical trials and beyond, an early 2021 perspective. viruses 13(3), 418 (2021).
Koch, T. et al. Correlates of vaccine-induced protection against SARS-CoV-2. Vaccines 9(3), 238 (2021).
Sui, Y., Bekele, Y. & Berzofsky, JA Potential SARS-CoV-2 immune correlates of protection in infection and vaccine immunization. pathogens 10(2), 138 (2021).
Dagotto, G., Yu, J. & Barouch, DH Approaches and challenges in SARS-CoV-2 vaccine development. Cell Host Microbe. 28364–370 (2020).
Sariol, A. & Perlman, S. Lessons for COVID-19 immunity from other coronavirus infections. Immunity 53248–263 (2020).
Sette, A. & Crotty, S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell 184(4), 861–880 (2021).
Huang, AT et al. A systematic review of antibody mediated immunity to coronaviruses, kinetics, correlates of protection, and association with severity. Nat. Commun. eleven(1), 1–16 (2020).
McMahan, K. et al. Correlates of protection against SARS-CoV-2 in rhesus macaques. Nature 590(7847), 630–634 (2021).
Simonovich, VA et al. A randomized trial of convalescent plasma in Covid-19 severe pneumonia. N. Engl. J. Med. 384(7), 619–629 (2021).
Iyer, A.S. et al. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. Sci. Immunol. 5(52), eabe0367 (2020).
Dan, JM et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science 371(6529), eabf4063 (2021).
Ward, BJ et al. Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19. Nat. Med. 27(6), 1071–1078 (2021).
Tang, F. et al. Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome, a six-year follow-up study. J. Immunol. Beef. 186(12), 7264–7268 (2011).
Ng, O.-W. et al. Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection. vaccine 3. 4(17), 2008–2014 (2016).
Hoareau, L. & DaSilva, EJ Medicinal plants, a re-emerging health aid. Electron. J. Biotechnol. two(2), 3–4 (1999).
Jahan, I. & Ahmet, ONAY Potentials of plant-based substance to inhabit and probable cure for the COVID-19. Turk. J. Biol. 44(SI-1), 228–241 (2020).
Andrighetti-Fröhner, CR et al. Antiviral evaluation of plants from Brazilian atlantic tropical forest. Phytotherapy 76(3–4), 374–378 (2005).
Alam, S. et al. Pharmacological and computer-aided studies provide new insights into millettia peguensis Ali (Fabaceae). Saudi Pharma. J. 28(12), 1777–1790 (2020).
Gakhar, A. Anti-viral phyto medicine, a review. J. Pharmacogn. Phytochem. 10(1), 2002–2004 (2021).
Yang, Y. et al. Traditional Chinese medicine in the treatment of patients infected with 2019-new coronavirus (SARS-CoV-2), a review and perspective. Int. J. Biol. Sci. 16(10), 1708 (2020).
Emon, NU et al. Antidepressant, anxiolytic, antipyretic, and thrombolytic profiling of methanol extract of the aerial part of Piper nigrumin vivo, in vitro, and in silico approaches. Food Sci.Nutr. 9(2), 833–846 (2021).
Ang, L. et al. Herbal medicine and pattern identification for treating COVID-19, a rapid review of guidelines. Integrate Med.Res. 9(2), 100407 (2020).
Alam, S. et al. Traditional herbal medicines, bioactive metabolites, and plant products against COVID-19, update on clinical trials and mechanism of actions. Front. Pharmacol. 121248 (2021).
Lekhooa, M. et al. Evaluation of traditional medicines II, the use of metabolite peak-kinetics to monitor PHELA in rat plasma. Afr. J. Tradit. Complement. Alternate. Med. 9(3S), 73–80 (2012).
Matsabisa et al. Internal Report, Medical Research Council, South Africa. (2006).
Lekhooa, M., Walubo, A., Du Plessis, JJ, Matsabisa, MC & Molefe, D. Evaluation of traditional medicines I, Identification of Phela using different chromatographic techniques. Afr. J. Tradit. Complement Alternate. Med. 9(3S), 27–39 (2012).
Lekhooa, M.R. et al. The development and use of a drug-induced immunosuppressed rat-model to screen Phela for mechanism of immune stimulation. J. Ethnopharmacol. 2068–18 (2017).
Das, b. et al. Anti-cholinesterase potential of standardized extract of PHELA a traditional South African medicine formulation. J.Herb. Med. 22100348 (2020).
Wei, X. et al. Antibody neutralization and escape by HIV-1. Nature 422(6929), 307–312 (2003).
Sanner, MF Python, a programming language for software integration and development. J. Mol. Graph Model 17(1), 57–61 (1999).
Morris, G.M. et al. AutoDock4 and AutoDockTools4, Automated docking with selective receiver flexibility. J. Comput. Chem. 30(16), 2785–2791 (2009).
Frisch, MJ, et al. Entering Gaussian System, Link 0= g09 Initial command,/home/software/g09/l1. exe/tmp/10epi_SRRRR_nmr/10epi_SRRRR_b3631_4_pbe_nmr/Gau-7875. inp-scrdir=/tmp/10epi_SRRRR_nmr/10epi_SRRRR_b3631_4_pbe_nmr/Entering Link 1=/home/software/g09/l1. exe PID=7876.
Trott, O. & Olson, AJ AutoDock Vina, improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31(2), 455–461 (2010).
Kannan, S.R. et al. Infectivity of SARS-CoV-2: There is something more than D614G?. J Neuroimmune. Pharmacol. fifteen(4), 574–577 (2020).
Wang, H. et al. The genetic sequence, origin, and diagnosis of SARS-CoV-2. Eur. J. Clin. microbiol. infect. Dis. 391629–1635 (2020).
Li, W. et al. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426(6965), 450–454 (2003).
Mobaraki, K. & Ahmadzadeh, J. Current epidemiological status of Middle East respiratory coronavirus syndrome in the world from 1.1.2017 to 17.1.2018, a cross-sectional study. BMC Infect. Dis. 19(1), 1–5 (2019).
Zhang, Y.-Z. & Holmes, EC A genomic perspective on the origin and emergence of SARS-CoV-2. Cell 181(2), 223–227 (2020).
Rabblert, J. et al. Activity of methanolic andrographis paniculate crude extract and its purified andrographolide against Japanese-encephalitis virus. Sci. Eng. Health Stud. fifteen21030007 (2021).
Zhang, H.-T. et al. Evaluation of the adjuvant efficacy of natural herbal medicine on COVID-19, a retrospective matched case-control study. Am. J. Chin. Med. 48(04), 779–792 (2020).
Bhuiyan, FR et al. Plant’s metabolites, possibility of natural therapeutics against the COVID-19 pandemic. Front. Med. 7444 (2020).
Ning, L. et al. Development and application of therapeutic antibodies against COVID-19. Int. J. Biol. Sci. 17(6), 1486 (2021).